莱沃多巴输液治疗帕金森病的输液疗法
Marissa N Dean1, David G Standaert
1Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Current opinion in neurology
|May 23, 2024
概括
连续的Levodopa疗法,包括Levodopa/Carbidopa肠凝 (LCIG) 和新的皮下 (SC) 选择,有效地管理帕金森病的运动波动,改善生活质量.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗技术 医疗技术 医学技术
背景情况:
- 帕金森病 (PD) 管理通常涉及解决运动波动和非运动症状.
- 标准的口服疗法在晚期PD可能变得不足.
- 连续药物输送系统为优化治疗水平提供了替代方案.
研究的目的:
- 对帕金森病的连续列伏多巴疗法的最新进展进行审查.
- 评估现有和新兴的连续乐伏多巴输送系统的有效性和应用.
主要方法:
- 审查最近的临床研究和关于连续利沃多巴治疗的数据.
- 莱沃多巴/卡尔比多巴肠凝 (LCIG) 和皮下 (SC) 莱沃多巴输送系统的分析.
- 评估疗效,安全性和生活质量的结果.
主要成果:
- 利沃多巴/卡尔比多巴肠凝 (LCIG) 有效地减少了"关闭"时间,控制了动力障碍,改善了帕金森病患者的非运动症状和生活质量.
- LCIG证明了长期的有效性和成本效益.
- 新兴的皮下 (SC) 列沃多巴输送系统 (ND0612,化/化) 在减少"关闭"时间方面表现有前途,皮肤反应是主要的不良影响.
结论:
- 持续的勒沃多巴疗法对于管理晚期帕金森病不响应口服药物的运动波动是有价值的.
- 这些疗法可以增强非运动症状,并改善帕金森病患者的整体生活质量.
相关概念视频
Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Drug Delivery: Parenteral Route
502
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
502
Direct-Acting Cholinergic Agonists: Therapeutic Uses
731
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
731
Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570


